Central, cardiovascular and metabolic effects of dexmedetomidine associated with the selective peripheral alpha₂-adrenoceptor antagonist MK-467 in dogs
Central, cardiovascular and metabolic effects of dexmedetomidine associated with the selective peripheral alpha₂-adrenoceptor antagonist MK-467 in dogs
Central, cardiovascular and metabolic effects of dexmedetomidine associated with the selective peripheral alpha₂-adrenoceptor antagonist MK-467 in dogs
Central, cardiovascular and metabolic effects of dexmedetomidine associated with the selective peripheral alpha₂-adrenoceptor antagonist MK-467 in dogs
Central, cardiovascular and metabolic effects of dexmedetomidine associated with the selective peripheral alpha₂-adrenoceptor antagonist MK-467 in dogs
Central, cardiovascular and metabolic effects of dexmedetomidine associated with the selective peripheral alpha₂-adrenoceptor antagonist MK-467 in dogs
Central, cardiovascular and metabolic effects of dexmedetomidine associated with the selective peripheral alpha₂-adrenoceptor antagonist MK-467 in dogs
Central, cardiovascular and metabolic effects of dexmedetomidine associated with the selective peripheral alpha₂-adrenoceptor antagonist MK-467 in dogs
Central, cardiovascular and metabolic effects of dexmedetomidine associated with the selective peripheral alpha₂-adrenoceptor antagonist MK-467 in dogs
Central, cardiovascular and metabolic effects of dexmedetomidine associated with the selective peripheral alpha₂-adrenoceptor antagonist MK-467 in dogs
Central, cardiovascular and metabolic effects of dexmedetomidine associated with the selective peripheral alpha₂-adrenoceptor antagonist MK-467 in dogs
Central, cardiovascular and metabolic effects of dexmedetomidine associated with the selective peripheral alpha₂-adrenoceptor antagonist MK-467 in dogs
Central, cardiovascular and metabolic effects of dexmedetomidine associated with the selective peripheral alpha₂-adrenoceptor antagonist MK-467 in dogs
Central, cardiovascular and metabolic effects of dexmedetomidine associated with the selective peripheral alpha₂-adrenoceptor antagonist MK-467 in dogs
Central, cardiovascular and metabolic effects of dexmedetomidine associated with the selective peripheral alpha₂-adrenoceptor antagonist MK-467 in dogs
Central, cardiovascular and metabolic effects of dexmedetomidine associated with the selective peripheral alpha₂-adrenoceptor antagonist MK-467 in dogs